Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells

Abstract excerpt

Background Rheumatoid arthritis (RA) is a chronic debilitating autoimmune disorder with a high prevalence, especially in industrialized countries. Dysbiosis of the intestinal microbiota has been observed in RA patients. For instance, new-onset untreated RA (NORA) is associated with the underrepresentation of the Clostridium cluster XIVa, including Lachnospiraceae, which are major butyrate producers, although the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Inflammatory Bowel Disease
• Share to Mycobacterium research and diagnosis
• Share to Pharmacological Effects of Natural Compounds